About Great Hill Partners
Great Hill Partners is a private equity firm specializing in financing the acquisition, recapitalization, or expansion of rapidly growing middle-market companies in a wide range of sectors within the business and consumer services, healthcare, media, communications, and software industries.
Great Hill Partners Headquarter Location
200 Clarendon Street 29th Floor
Boston, Massachusetts, 02116,
Latest Great Hill Partners News
Sep 22, 2021
IVX Health Secures $100 Million Growth Investment from Great Hill Partners to Accelerate New Market Expansion NASHVILLE, Tenn. & BOSTON, September 21, 2021-- IVX Health, a national provider of outpatient infusion centers, announced today the completion of a $100 million Series F minority investment from Great Hill Partners, a private equity firm that invests in high-growth, disruptive companies. Great Hill joins IVX Healths existing investors including Linden Structured Capital, McKesson Ventures, Health Velocity Capital, and Nueterra Capital. IVX Health offers an alternative to hospital-based infusion and injection services, transforming the patient experience by providing a superior level of service in a cost-effective, convenient site of care. Its local centers offer guaranteed private suites, large flat screen TVs, high-speed Wi-Fi, leather recliners with chairs for guests, and flexible, on-demand scheduling, including evening and weekend appointments. Operating over 50 infusion centers across 16 markets, IVX Health will immediately utilize the funding to accelerate entry into new markets in 2022 and beyond as it seeks to fulfill its vision of becoming the nations preferred destination of pharmaceutical care for patients with complex chronic conditions such as multiple sclerosis, Crohn's disease, and rheumatoid arthritis, among others. Our primary goal has always been to provide world-class service and clinical excellence to the patients we serve, said Doug Ghertner, CEO of IVX Health. IVX and Great Hill both see an inflection point in infusion therapy, as the growth in diagnosed autoimmune conditions and trends toward patient choice have aligned with an uptick in innovative new therapies. Many patients are unfortunately still left with few options for receiving this life-changing care, often within a crowded infusion room of a hospital and thats where we come in. We are confident that Great Hills investment and deep domain expertise will help us address this shortage of care options by enabling IVX to bring our unique clinical model and patient-centered amenities to an even broader universe of patients. IVX Health is disrupting a distinct and rapidly growing healthcare vertical biologic infusion and injection therapy in unique ways that are driving tangible efficiencies for the U.S. healthcare system as a whole, said Mark Taber, a Managing Director at Great Hill Partners. We are excited to play a strategic, supporting role in fueling IVX Healths next phase of growth as it enters new markets and collaborates with other providers in the healthcare ecosystem to drive value while continuing to redefine the care experience for its patients and referring providers. In connection with the investment, Taber will join IVX Healths Board of Directors. Taber brings decades of executive healthcare experience from his time as Managing Director at Great Hill and as a board member of various portfolio companies. In addition to IVX Health, Great Hills portfolio of healthcare companies includes: RxBenefits, Quantum Health, Labor First, ParetoHealth, and Vatica Health. Todays announcement deepens Great Hills experience partnering with innovative healthcare companies to help them pursue their full potential, which includes the recently-sold company, PartsSource, a leading provider of medical parts and supplies procurement solutions for hospitals, outpatient clinics, and physician offices. IVX Healths capital raise builds on what has already been a banner year for the company, as it has achieved record milestones for opening new centers, caring for new patients, and entering new states. IVX Health was also named to the prestigious Modern Healthcare Best Places to Work list for a third consecutive year. The organization continues to maintain an industry-leading 97 Net Promoter Score from its patient population. Evercore served as financial advisor to IVX Health and TripleTree, LLC served as financial advisor to Great Hill. About IVX Health IVX Health is a national provider of infusion and injection therapy for those with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis and other conditions. IVX Healths national footprint of outpatient infusion centers are conveniently located in the communities where patients live and work. IVX Healths experience-first model includes amenities such as flexible appointment scheduling with evening and weekend availability, guaranteed private suites, high-speed Wi-Fi, flat screen TVs with streaming TV and movies, and comfortable recliners with room for guests. For more information on IVX Health and its existing locations, visit www.ivxhealth.com. About Great Hill Partners Great Hill Partners is a Boston-based private equity firm targeting investments of $25 million to $500 million in high-growth companies across the software, digital commerce, financial technology, healthcare, and digital infrastructure sectors. Over the past two decades, Great Hill has raised nearly $8 billion of commitments and invested in more than 75 companies, establishing an extensive track record of building long-term partnerships with entrepreneurs and providing flexible resources to help middle-market companies scale. For more information, including a list of all Great Hill investments, visit www.greathillpartners.com. Contact:
Great Hill Partners Team
21 Team Members
Great Hill Partners has 21 team members, including current Chief Financial Officer, John Ahmad.